demonstrated that the kinase DYRK1A is overexpressed and crucial for BCP-ALL progression; inhibition of DYRK1A and subsequent activation of FOXO1 led to DNA-damage-mediated cell death (98). This evidence concerns the gene DYRK1A and acute lymphoblastic leukemia.